BioSpace News Archive

Greenphire, the global leader in financial software for clinical trials, today announced the launch of its ConneX Patient Direct service to enable global clinical trial sites to continue their critical work and patient support in an effort to offset the impact of COVID-19

Global Health Trax has expanded their product line once again, adding a third tier to their venerable series of probiotic supplements.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continued to grow during the first quarter of 2020, with more than 700 candidates awaiting insurance reimbursement authorization as of March 31, 2020. This compares

System demonstrates ability to restore ventilation to acute respiratory distress syndrome-damaged lungs

Healthcare organizations have a new resource to help them solve critical revenue cycle management (RCM) challenges. The VisiQuateCOVID-19 Revenue Cycle Resource Center includes step-by-step plays and blog posts informed by the company’s deep expertise.

The tenth annual Pharmaceutical Innovation Index, released by IDEA Pharma today, sees Roche top the industry for the first time.

OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors.

AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today updated survival data from a year-end analysis of its ongoing Phase 2 clinical trial of AV-GBM-1 in patients with newly diagnosed glioblastoma (GBM). In the analysis, the overall survival rate at both 12 and 1

COVID-19 treatment candidate, a high-potency immunotherapy delivering human polyclonal antibodies targeted to SARS-CoV-2, generated from SAB’s novel platform technology, on-track for clinical evaluation as early as summer [08-April-2020] KING OF PRUSSIA, Pa. and SIOUX FALLS, S.D. , April 8, 2020 /PRNewswire/ -- Global biotherapeutics leader, CSL Behring and innova

Andor Health’s ThinkAndor™ platform to push critical notifications to NIH Clinical Center teams, providers and patients, while increasing overall operational efficiency